Skip to main content
. 2022 Aug 3;14:975176. doi: 10.3389/fnagi.2022.975176

TABLE 4.

The trend and function of phosphatidylserine (PS) in central nervous system (CNS) disease.

Disease Trend of PS Function of PS PS improves disease

Patient Animal model
AD Inconsistent Inconsistent Increase dendritic spine, increase acetylcholine, inhibit the microglial activation and tau hyperphosphorylation Yes
PD Up Up Initiate and enhance aggregation of α-Syn, function as carrier to deliver other drugs Yes
MDD Up Up Blunt the activation of hypothalamus pituitary adrenal axis, attenuate the cytotoxicity of corticosterone Yes
Stroke No data Down Reduced PS decrease the activity of PKC, PS liposomes inhibit inflammation No data
ASD down No data No data No data
ADHD No data No data No data Yes
Schizophrenia inconsistent No data No data No data
SCI No data Down No data No data